Violation Tracker Individual Record
Company:
Mylan Inc.
Current Parent Company:
Viatris
Penalty:
$465,000,000
Year:
2017
Date:
August 17, 2017
Offense Group:
government-contracting-related offenses
Primary Offense:
False Claims Act and related
Violation Description:
Mylan Inc. and Mylan Specialty L.P. agreed to pay $465 million to resolve claims that they violated the False Claims Act by knowingly misclassifying EpiPen as a generic drug to avoid paying rebates owed primarily to Medicaid.
Level of Government:
federal
Action Type:
agency action
Agency:
Justice Department Civil Division
Civil or Criminal Case:
civil
HQ Country of Parent:
USA
HQ State of Parent:
Pennsylvania
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
